United States securities and exchange commission logo




                                                                                
                         March 11, 2024

       Linda Rubinstein
       Chief Financial Officer
       Adverum Biotechnologies, Inc.
       100 Cardinal Way
       Redwood City, California 94063

                                                        Re: Adverum 
Biotechnologies, Inc.
                                                            Registration 
Statement on Form S-3
                                                            Filed March 4, 2024
                                                            File No. 333-277634

       Dear Linda Rubinstein:

               Our initial review of your registration statement indicates that 
it fails in numerous
       material respects to comply with the requirements of the Securities Act 
of 1933, the rules and
       regulations thereunder and the requirements of the form. More 
specifically, it does not appear
       that financial statements complying with the updating requirements of 
Rule 8-08 of Regulation
       S-X are presented in your registration statement.

              We will provide more detailed comments relating to your 
registration statement
       following our review of a substantive amendment that addresses these 
deficiencies.

                                                        Please contact Tamika 
Sheppard at 202-551-8346 with any questions.



                                                                                
                         Sincerely,

                                                                                
                         Division of Corporation Finance
                                                                                
                         Office of Life Sciences
       cc:                                              Kenneth Guernsey